Testosterone replacement therapy should be simple. The compound has been studied for nearly a century. The pharmacology is well understood. The benefits are documented across thousands of clinical trials.
And yet, the modern TRT industry has managed to complicate something straightforward into a confusing, expensive, and often counterproductive experience for the men it’s supposed to help.
I’ve been on testosterone replacement for over 15 years. I’ve operated in the clinical space. I’ve seen the business model from the inside. And I’ve made enough mistakes — and watched enough other men make them — to know exactly where the system fails.
This is Part 1 of a three-part series. Today: the lies. Next: the framework. Then: the advanced optimization plays.
Lie #1: “Your Levels Are Normal”
The standard evaluation for testosterone in most medical settings looks at a single number: total testosterone. If that number falls anywhere within a reference range — typically 250 to 1100 ng/dL — you’re told you’re normal and sent home.
This is inadequate to the point of being negligent.
Total testosterone represents the combined bound and unbound testosterone in your blood. Roughly 98% of it is bound to either SHBG or albumin. Only the remaining 2% — free testosterone — is biologically active.
A man with a total testosterone of 500 ng/dL and low SHBG might have excellent free testosterone and feel great. A man with a total T of 700 and elevated SHBG might have poor free T and feel terrible. The total number tells you almost nothing without context.
The reference ranges themselves are derived from population averages that increasingly include metabolically unhealthy men. The “normal” range has been revised downward over the decades — not because male physiology changed, but because the average man became less healthy.
Lie #2: “200mg Every Two Weeks Is Standard Protocol”
This is the protocol most general practitioners learned in medical school and have never revisited. It remains the most commonly prescribed TRT regimen. And it is, by modern standards, a poor protocol for the majority of men.
Testosterone cypionate has a half-life of approximately 8 days. When you inject 200mg and wait 14 days, you create a pronounced spike-and-crash pattern. Days 1-4: supraphysiological levels, you feel incredible. Days 10-14: levels below your pre-treatment baseline, you feel worse than before you started.
The solution is straightforward: smaller doses administered more frequently produce dramatically more stable blood levels. Twice-weekly injection is the minimum. Every-other-day and daily subcutaneous protocols produce even flatter curves with less estrogen conversion.
The barrier is not scientific. It’s logistical and economic. More frequent injection requires more patient education, which most clinics aren’t structured to provide. This is a direct application of the Tony Huge Laws of Biochemistry Physics — receptor saturation and clearance rates dictate that stable hormone levels produce superior outcomes to massive peaks and troughs.
Lie #3: “You Need an Aromatase Inhibitor From Day One”
Many TRT clinics prescribe an aromatase inhibitor — typically Anastrozole — alongside testosterone from the first injection. In most cases, this is premature and potentially harmful.
The consequences of suppressed estrogen in men are significant: joint pain, severe libido reduction, cognitive impairment, mood instability, bone density loss, and adverse lipid changes. Estradiol is not a female hormone that men should minimize. It’s a critical signaling molecule that protects cardiovascular, neurological, and skeletal health.
The appropriate approach is sequential. Start testosterone. Optimize injection frequency. Allow 6-8 weeks for steady state. Draw comprehensive bloodwork including sensitive estradiol. Evaluate in context with symptoms. If estradiol is elevated AND symptomatic, THEN introduce a low-dose AI and titrate carefully.
Prescribing an AI before observing how a patient’s body handles testosterone is treating a problem that may not exist.
Lie #4: “There’s a Standard TRT Dose”
Every human body processes testosterone differently. Metabolism, SHBG levels, body composition, aromatase activity, and genetics all influence how a given dose translates to blood levels and subjective experience.
I’ve observed men who achieve optimal well-being on 80mg per week. Others require 160mg per week for the same outcome. Putting every patient on 200mg is assembly-line medicine.
The principle: find the lowest amount of exogenous testosterone that produces optimal subjective well-being while keeping all biomarkers in range. More is not better. More creates more aromatization, more hematocrit elevation, more lipid disruption.
Start conservative — 100-120mg per week. Allow 6 weeks for steady state. Evaluate with comprehensive bloodwork AND symptom assessment. Adjust by 10-20mg increments. This process typically takes 3-6 months. Any clinic that promises optimization in one visit is selling convenience, not medicine.
Interesting Perspectives
While the core principles of TRT are established, the field is evolving. One emerging perspective is the consideration of testosterone as a metabolic regulator, not just a sex hormone. Some clinicians are observing that optimal TRT can improve insulin sensitivity and mitochondrial function, suggesting its role in men’s health is broader than libido and muscle mass. Another unconventional angle is the exploration of very-low-dose daily protocols (e.g., 10-15mg testosterone daily via subcutaneous injection) to mimic the body’s natural ultradian rhythm, potentially minimizing side effects like erythrocytosis. There’s also a growing contrarian discussion around the long-term use of HCG (human chorionic gonadotropin) alongside TRT, not just for fertility preservation but for maintaining testicular interstitial cell health and possibly a more balanced neurosteroid profile, which some report impacts mood and cognition differently than testosterone alone.
Part 2 of The TRT Bible — The Complete Optimization Framework — publishes next week. Part 3 covers Advanced Protocols for the experienced user.
Citations & References
This article is based on clinical experience and established endocrinology principles. For foundational research on testosterone therapy, consult the following:
- Bhasin, S., et al. (2010). Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism.
- Wang, C., et al. (2009). Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations. European Urology.
- Finkelstein, J. S., et al. (2013). Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men. New England Journal of Medicine.
- Morgentaler, A., et al. (2016). Testosterone Deficiency and Cardiovascular Mortality. Asian Journal of Andrology.
- Traish, A. M. (2018). Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews.
This content is educational. Consult a qualified provider before beginning any hormone protocol.